Quick summary
Melaleuca ericifolia, commonly known as Rosalina, is a plant species with pending research status. Current literature directly focusing on its clinical effects in humans is limited or lacking. Existing studies and reviews related to Melaleuca species reveal some constituents with potential biological activity but no definitive human clinical evidence for Rosalina is available.
What is it
Rosalina (Melaleuca ericifolia) is a member of the Melaleuca genus, a group of plants native to Australia known for their aromatic essential oils. This species has attracted interest primarily for its chemical constituents, though direct clinical research specific to Rosalina remains scarce.
Traditional uses
Traditional uses of Melaleuca species generally include applications for skin conditions, respiratory issues, and minor infections due to their antiseptic properties. However, specific traditional uses of Melaleuca ericifolia have not been well documented in the available literature.
Active compounds
Compounds identified in Melaleuca ericifolia include volatile oils and triterpenes, which are biologically active molecules also found in related Melaleuca species. Some of these compounds have demonstrated antibacterial, anti-inflammatory, and antiproliferative activities in laboratory and animal studies.
Potential benefits with evidence levels
- Insufficient clinical evidence: No published human clinical trials or systematic reviews specifically investigating Melaleuca ericifolia were identified.
- Preclinical evidence only: Related Melaleuca species or compounds from similar plants have shown antibacterial, anti-inflammatory, and antiproliferative activities in vitro and in animal models, suggesting possible biological effects that have yet to be confirmed in humans.
Side effects
There are no documented adverse effects of Melaleuca ericifolia in human clinical studies based on the current available information.
Drug interactions
No information regarding drug interactions involving Melaleuca ericifolia was identified in the current data.
Who should avoid it
There are no established contraindications for Melaleuca ericifolia use based on the supplied evidence. However, due to the lack of safety data, pregnant and breastfeeding women should exercise caution and consult a healthcare provider before use.
Evidence limitations
The main limitation is the absence of clinical trials, systematic reviews, or meta-analyses directly involving Melaleuca ericifolia in humans. Available information is limited to unrelated or preclinical studies of related Melaleuca species or extracts from other plants. Therefore, no evidence-based conclusions on efficacy or safety in humans can be made at this time.
References
- Zhang L, Lokeshwar BL. Medicinal properties of the Jamaican pepper plant Pimenta dioica and Allspice. Europe PMC. 2012.
- Lin YP, Edwards RD, Kondo T, Semple TL, Cook LG. Species delimitation in asexual insects of economic importance: The case of black scale (Parasaissetia nigra), a cosmopolitan parthenogenetic pest scale insect. Europe PMC. 2017.
- Melaleuca ericifolia. CABI Compendium. 2019.
- Antiproliferative Triterpenes from Melaleuca ericifolia. Journal of Natural Products. 2008.
- IN VITRO VOLATILE OIL PRODUCTS OF MELALEUCA ERICIFOLIA SMITH. Acta Horticulturae. 2003.
Last reviewed
June 2024
Informational disclaimer
The information provided here is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before using any herbal supplements or making changes to your health regimen.